Tellus Therapeutics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $35M

  • Investors
  • 5

Tellus Therapeutics General Information

Description

Operator of a biopharmaceutical company intended to develop safe and effective treatments for unmet needs in newborns. The company's drug induces regeneration of myelin-producing oligodendrocytes and reverses white matter injury in premature babies, enabling physicians to provide treatment for every baby born at risk for brain injury and improve neurodevelopmental outcomes for affected children.

Contact Information

Website
www.tellustherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 517 Summit Trail Drive
  • Hillsborough, NC 27278
  • United States
+1 (919)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 517 Summit Trail Drive
  • Hillsborough, NC 27278
  • United States
+1 (919)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tellus Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Early Stage VC (Series A) 13-Dec-2022 $35M Completed Pre-Clinical Trials
6. Grant 08-Dec-2020 Completed Pre-Clinical Trials
5. Grant Completed Pre-Clinical Trials
4. Grant 30-Sep-2020 Completed Pre-Clinical Trials
3. Debt - General 01-Dec-2019 Completed Pre-Clinical Trials
2. Accelerator/Incubator 24-Oct-2019 $100K $175K Completed Pre-Clinical Trials
1. Accelerator/Incubator 31-Jan-2019 $75K $75K Completed Pre-Clinical Trials
To view Tellus Therapeutics’s complete valuation and funding history, request access »

Tellus Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
To view Tellus Therapeutics’s complete cap table history, request access »

Tellus Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biopharmaceutical company intended to develop safe and effective treatments for unmet needs in newborns. T
Drug Discovery
Hillsborough, NC
8 As of 2025

San Diego, CA
 

Roseville, MN
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Tellus Therapeutics Competitors (9)

One of Tellus Therapeutics’s 9 competitors is Novoron Bioscience, a Venture Capital-Backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Novoron Bioscience Venture Capital-Backed San Diego, CA
Rebiotix Formerly VC-backed Roseville, MN
Enterome Venture Capital-Backed Paris, France
CosmosID Formerly VC-backed Germantown, MD
Eligo Bioscience Venture Capital-Backed Paris, France
You’re viewing 5 of 9 competitors. Get the full list »

Tellus Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tellus Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Perceptive Advisors Venture Capital Minority
National Institutes of Neurological Disorders and Stroke Government
MassChallenge Accelerator/Incubator
MedBlue Incubator Accelerator/Incubator
Duke University Medical Center University
To view Tellus Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Tellus Therapeutics FAQs

  • When was Tellus Therapeutics founded?

    Tellus Therapeutics was founded in 2018.

  • Where is Tellus Therapeutics headquartered?

    Tellus Therapeutics is headquartered in Hillsborough, NC.

  • What is the size of Tellus Therapeutics?

    Tellus Therapeutics has 8 total employees.

  • What industry is Tellus Therapeutics in?

    Tellus Therapeutics’s primary industry is Drug Discovery.

  • Is Tellus Therapeutics a private or public company?

    Tellus Therapeutics is a Private company.

  • What is the current valuation of Tellus Therapeutics?

    The current valuation of Tellus Therapeutics is .

  • What is Tellus Therapeutics’s current revenue?

    The current revenue for Tellus Therapeutics is .

  • How much funding has Tellus Therapeutics raised over time?

    Tellus Therapeutics has raised $35.4M.

  • Who are Tellus Therapeutics’s investors?

    Perceptive Advisors, National Institutes of Neurological Disorders and Stroke, MassChallenge, MedBlue Incubator, and Duke University Medical Center have invested in Tellus Therapeutics.

  • Who are Tellus Therapeutics’s competitors?

    Novoron Bioscience, Rebiotix, Enterome, CosmosID, and Eligo Bioscience are some of the 9 competitors of Tellus Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »